The schizophrenia syndrome, circa 2024: What we know and how that informs its nature

R Tandon, H Nasrallah, S Akbarian… - Schizophrenia …, 2024 - Elsevier
With new data about different aspects of schizophrenia being continually generated, it
becomes necessary to periodically revisit exactly what we know. Along with a need to review …

[HTML][HTML] Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations …

B Fischer, T Robinson, C Bullen, V Curran… - International Journal of …, 2022 - Elsevier
Background Cannabis use is common, especially among young people, and is associated
with risks for various health harms. Some jurisdictions have recently moved to …

Self-isolation: A significant contributor to cannabis use during the COVID-19 pandemic

SJ Bartel, SB Sherry, SH Stewart - Substance abuse, 2020 - journals.sagepub.com
Background Emerging research suggests the COVID-19 pandemic has resulted in a
significant increase in self-reported isolation and loneliness in a large proportion of the …

Association between non-medical cannabis legalization and emergency department visits for cannabis-induced psychosis

DT Myran, M Pugliese, RL Roberts, M Solmi… - Molecular …, 2023 - nature.com
A major public health concern of cannabis legalization is that it may result in an increase in
psychotic disorders. We examined changes in emergency department (ED) visits for …

Psychosis superspectrum I: Nosology, etiology, and lifespan development

KG Jonas, TD Cannon, AR Docherty, D Dwyer… - Molecular …, 2024 - nature.com
This review describes the Hierarchical Taxonomy of Psychopathology (HiTOP) model of
psychosis-related psychopathology, the psychosis superspectrum. The HiTOP psychosis …

Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis

T Robinson, MU Ali, B Easterbrook, W Hall… - Psychological …, 2023 - cambridge.org
BackgroundEpidemiological studies show a dose–response association between cannabis
use and the risk of psychosis. This review aimed to determine whether there are identifiable …

Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis

T Robinson, MU Ali, B Easterbrook… - Drug and Alcohol …, 2022 - Elsevier
Background Cannabis use disorder (CUD) affects one-in-five cannabis users, presenting a
major contributor to cannabis-associated disease burden. Epidemiological data identify the …

Cannabidiol and neurodegeneration: From molecular mechanisms to clinical benefits

SK Jha, VK Nelson, PR Suryadevara, SP Panda… - Ageing Research …, 2024 - Elsevier
Neurodegenerative disorders (NDs) such as Alzheimer's disease, Parkinson's disease,
Huntington's disease, multiple sclerosis, and amyotrophic lateral sclerosis are severe and …

Clinical management of cannabis withdrawal

JP Connor, D Stjepanović, AJ Budney, B Le Foll… - …, 2022 - Wiley Online Library
Abstract Background and Aims Cannabis withdrawal is a well‐characterized phenomenon
that occurs in approximately half of regular and dependent cannabis users after abrupt …

Associations between Canada's cannabis legalization and emergency department presentations for transient cannabis-induced psychosis and schizophrenia …

RC Callaghan, M Sanches, RM Murray… - The Canadian …, 2022 - journals.sagepub.com
Objective Cannabis legalization in many jurisdictions worldwide has raised concerns that
such legislation might increase the burden of transient and persistent psychotic illnesses in …